De-risk Drug Development AI is an advanced tool leveraging the power of AI to increase the probability of success in drug development. It offers solutions to uncover actionable insights in clinical development by measuring the likelihood of success across therapeutic areas and providing AI-driven risk assessments.

The tool helps in identifying underlying drivers contributing to technical and regulatory risks, optimizing clinical trial design, and standardizing risk evaluation processes. With transparent and explainable AI features, it empowers users to make confident decisions based on quality, harmonized data and eliminate the mysterious AI black box.